SEC Form 4 · accession 0001213900-18-016587
IMMUCELL CORP /DE/ · ICCC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph H Crabb
Officer — Vice President and CSO
Period of report
Nov 26, 2018
Accepted (ET)
Nov 27, 2018 · 4:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000811641
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.10 per share | Nov 26, 2018 | D | 10,766 | $7.50 | D | 94,345 | D | |
| Common Stock, par value $0.10 per share | Nov 26, 2018 | M | 47,500 | $1.70 | A | 141,845 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Options | $1.70 | Nov 26, 2018 | M | — | D | Jan 9, 2012 | Jan 8, 2019 | Common Stock | 47,500 | 2 | D |